7767 50 Pill - white brown capsule-shape, 18mm
Generic Name: celecoxib
Pill with imprint 7767 50 is White / Brown, Capsule-shape and has been identified as Celebrex 50 mg. It is supplied by Pfizer U.S. Pharmaceuticals Group.
Celebrex is used in the treatment of osteoarthritis; ankylosing spondylitis; familial adenomatous polyposis; juvenile rheumatoid arthritis; pain and belongs to the drug class cox-2 inhibitors. prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Celebrex 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 7767 50


Celebrex
- Generic Name
- celecoxib
- Imprint
- 7767 50
- Strength
- 50 mg
- Color
- White / Brown
- Size
- 18.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Cox-2 inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out - prior to 30 weeks gestation, D - Positive evidence of risk - starting at 30 weeks gestation
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pfizer U.S. Pharmaceuticals Group
- Inactive Ingredients
-
croscarmellose sodium,
lactose monohydrate,
magnesium stearate,
sodium lauryl sulfate
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00025-1515 | Pfizer Inc. |
68180-0596 (Discontinued) | Lupin Pharmaceuticals, Inc. |
00378-4065 (Discontinued) | Mylan Pharmaceuticals Inc. |
59762-1515 | Viatris |
00591-2817 (Discontinued) | Watson Pharmaceuticals, Inc. |
Related images for "7767 50"
More about Celebrex (celecoxib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (215)
- Drug images
- Latest FDA alerts (6)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Generic availability
- Support group
- Drug class: cox-2 inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.